August 15, 2025 a 12:39 pm
CI: Analysts Ratings - The Cigna Group
The Cigna Group has demonstrated consistent value in the insurance and health services sector. Analyst ratings over the recent months illustrate a generally positive outlook, with a stable number of 'Buy' and 'Strong Buy' recommendations. Overall, The Cigna Group remains an influential player with room for strategic growth.
Historical Stock Grades
The following table depicts the latest analyst ratings for The Cigna Group. It reflects the general sentiment and recommendations within the industry as of August 2025.
| Grade | Count | Score |
|---|---|---|
| Strong Buy | 6 | |
| Buy | 13 | |
| Hold | 5 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
The sentiment around The Cigna Group’s stock has remained relatively steady, with a small fluctuation in 'Buy' and 'Strong Buy' recommendations over recent months. Here are key observations:
- Strong Buy ratings have slightly decreased from 8 (as of late 2024) to 6 in mid-2025.
- 'Buy' ratings have seen a modest decrease, indicating a cautious but positive outlook from analysts.
- Hold ratings have increased slightly, reflecting a sense of caution or anticipated stabilization.
Percentage Trends
Analyst ratings have shown slight shifts in percentage terms across the recommendation categories. This shift underscores subtle changes in market confidence:
- Strong Buy decreased from approximately 21% to 19% of total ratings from early 2024 to mid-2025.
- Buy ratings have seen a decrease in percentage from 44% to 41% during the same period.
- Hold ratings have increased marginally, signifying a balanced market outlook, rising from 10% to 16%.
Overall, there is a perceptible consolidation with more ratings gravitating toward conservative 'Hold' positions.
Latest Analyst Recommendations
Below is a table showing the latest analyst recommendations without significant changes in their sentiment toward The Cigna Group:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-14 | Outperform | Outperform | Baird |
| 2025-08-14 | Equal Weight | Equal Weight | Wells Fargo |
| 2025-08-04 | Buy | Buy | Guggenheim |
| 2025-08-01 | Overweight | Overweight | Barclays |
| 2025-06-26 | Outperform | Outperform | RBC Capital |
Analyst Recommendations with Change of Opinion
There have been instances of changed opinions in the last year. Here are notable changes:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2024-02-05 | Overweight | Neutral | Cantor Fitzgerald |
| 2024-02-05 | Outperform | Sector Perform | RBC Capital |
| 2024-02-01 | Buy | Hold | Deutsche Bank |
| 2024-01-04 | Outperform | Market Perform | Bernstein |
| 2023-12-11 | Buy | Hold | Jefferies |
Interpretation
The Cigna Group's stock maintains a relatively stable and positive outlook despite some fluctuations in ratings. The consistent number of strong and buy recommendations indicates a steady confidence in the company's performance and market position. However, the slight increase in hold ratings suggests a more cautious approach moving forward due to market uncertainties. Analysts' sentiments remain robust, although the emergence of increased hold recommendations depicts a slight shift towards potential stabilization in the company's growth prospects.
Conclusion
The Cigna Group exhibits a solid market position with potential for growth in the dynamic insurance and healthcare sector. Despite minor dips in the strong buy and buy recommendations, the general sentiment remains positive, indicating a trusted brand with a sustainable market approach. Analysts appear to remain confident about Cigna's offerings and strategies, although the increased caution in recommendations suggests that stakeholders may be awaiting further clarity on economic conditions before shifting their outlook. Overall, The Cigna Group is poised for potential upside, with the current cautious optimism reflected in the latest ratings.